Approximately 112 diabetic COVID-19 patients were selected. One group received metformin + standard therapy while the other group received sitagliptin in addition to metformin + standard therapy and CRP, ferrin, procalcitonin, D-dimer, LDH were measured. This evidence concerns the gene FERRISR and COVID-19.